Literature DB >> 1321636

Effects of cisplatin on human thyrocytes in monolayer or follicle culture.

C Massart1, C Le Tellier, C Lucas, J Gibassier, G Leclech, M Nicol.   

Abstract

Cis-diamminedichloroplatinum (II) (cisplatin) is a widely used anticancer drug which induces many side-effects, but its action on the thyroid gland is still unknown. We have investigated the effects of this drug on human thyrocytes cultured in monolayers or in follicles and stimulated with 200 microU TSH/ml. After 72 h in culture, different concentrations of cisplatin (15, 30 and 75 microM) caused partial or total inhibition of cyclic AMP (cAMP), thyroglobulin (Tg) and tri-iodothyronine (T3) production, whereas thyroxine levels increased in the medium of thyrocytes cultured as follicles. Small doses of the drug did not affect thyrocyte production. Decreases in neutral-red uptake by thyroid cells and in intracellular lactate dehydrogenase, alpha-hydroxybutyryldehydrogenase and creatine phosphokinase activities were induced by 30 and 75 microM cisplatin. These data show that high concentrations of cisplatin had a cytotoxic effect on thyrocytes. Cisplatin also induced inhibition of the production of cAMP, Tg and T3.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1321636     DOI: 10.1677/jme.0.0080243

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  4 in total

Review 1.  Thyroid dysfunction from antineoplastic agents.

Authors:  Ole-Petter Riksfjord Hamnvik; P Reed Larsen; Ellen Marqusee
Journal:  J Natl Cancer Inst       Date:  2011-10-18       Impact factor: 13.506

2.  Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy.

Authors:  Mohd Ashif Khan; Kamlesh Garg; Dinesh Bhurani; Nidhi Bharal Agarwal
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-08-27       Impact factor: 3.000

3.  In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules.

Authors:  R D Christen; A P Jekunen; J A Jones; F Thiebaut; D R Shalinsky; S B Howell
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Thyroid dysfunction in patients with childhood-onset medulloblastoma or primitive neuroectodermal tumor.

Authors:  Seung Young Jin; Jung Yoon Choi; Kyung Duk Park; Hyoung Jin Kang; Hee Young Shin; Ji Hoon Phi; Seung-Ki Kim; Kyu-Chang Wang; Il Han Kim; Young Ah Lee; Choong Ho Shin; Sei Won Yang
Journal:  Ann Pediatr Endocrinol Metab       Date:  2018-06-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.